FDA Inspection 621686 — Joslin Diabetes Center Committee On Human Studies

Joslin Diabetes Center Committee On Human Studies — FEI 1283624

The FDA completed an inspection of Joslin Diabetes Center Committee On Human Studies on Oct 2, 2009 in Boston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 2, 2009
Fiscal Year
2010
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional details

IRB

Citations

IDCFRDescription
728121 CFR 56.108(a)(1)Initial and continuing reviews
736921 CFR 56.109(h)Children as subjects
737121 CFR 56.108(a)(1)Reporting findings and actions to investigator/institution

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.